Hi Guys
I held for far too many years, on the strength of too many hollow promises.
Initially it was all about gold in Burkina Faso, then Watershed, then back to BK, then gold in Queensland.
I gave up and took a large loss at 1.7c because even then there was too much debt to repay to McQuarie, let alone raising any more without a massive dilution for any mooted development of Wathershed?.
Mark may have had good intentions but cried wolf too many times, but certainly enjoyed a luxuriously high salary, all whilst destroying retail shareholders capital.
As those at Shark Tank say "for those reasons I'm out" and happy to be out.
I do however hope for those still in, it works out, but I'd be very cautious because $150mill is a very small prize in mining return terms given the risks and given (by example Wolf resources) which is already producing in the UK was once a 40c stock and now I think they are languishing at only .05c?. Why?.
Sarg
- Forums
- ASX - By Stock
- VML
- Ann: Watershed Tungsten Project Optimisation Studies Boost Value
Ann: Watershed Tungsten Project Optimisation Studies Boost Value, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VML (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.79M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $41 | 20.40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
82 | 94170524 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 43857649 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
82 | 94170524 | 0.002 |
31 | 169362531 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 43857649 | 54 |
0.004 | 11066594 | 27 |
0.005 | 22171024 | 23 |
0.006 | 5967649 | 10 |
0.007 | 1217296 | 3 |
Last trade - 13.23pm 13/11/2024 (20 minute delay) ? |
Featured News
VML (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online